Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo

  • Robinson Joannides
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • Walter E. Haefeli
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • Lilly Linder
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • Vincent Richard
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • El Hassan Bakkali
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • Christian Thuillez
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).
  • Thomas F. Lüscher
    From the Department of Pharmacology, VACOMED, IFRMP, Rouen University Medical School and Rouen Hospital (France) (R.J., V.R., E.H.B., C.T.) and the Department of Clinical Pharmacology, Basel University Hospital (Switzerland) (W.E.H., L.L., T.F.L.).

書誌事項

公開日
1995-03
DOI
  • 10.1161/01.cir.91.5.1314
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:p> <jats:italic>Background</jats:italic> Experimental evidence suggests that flow-dependent dilatation of conduit arteries is mediated by nitric oxide (NO) and/or prostacyclin. The present study was designed to assess whether NO or prostacyclin also contributes to flow-dependent dilatation of conduit arteries in humans. </jats:p> <jats:p> <jats:italic>Methods and Results</jats:italic> Radial artery internal diameter (ID) was measured continuously in 16 healthy volunteers (age, 24±1 years) with a transcutaneous A-mode echo-tracking system coupled to a Doppler device for the measurement of radial blood flow. In 8 subjects, a catheter was inserted into the brachial artery for measurement of arterial pressure and infusion of the NO synthase inhibitor <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -monomethyl- <jats:sc>l</jats:sc> -arginine (L-NMMA; 8 μmol/min for 7 minutes; infusion rate, 0.8 mL/min). Flow-dependent dilatation was evaluated before and after L-NMMA or aspirin as the response of the radial artery to an acute increase in flow (reactive hyperemia after a 3-minute cuff wrist occlusion). Under control conditions, release of the occlusion induced a marked increase in radial blood flow (from 24±3 to 73±11 mL/min; <jats:italic>P</jats:italic> <.01) followed by a delayed increase in radial diameter (flow-mediated dilatation; from 2.67±0.10 to 2.77±0.12 mm; <jats:italic>P</jats:italic> <.01) without any change in heart rate or arterial pressure. L-NMMA decreased basal forearm blood flow (from 24±3 to 13±3 mL/min; <jats:italic>P</jats:italic> <.05) without affecting basal radial artery diameter, heart rate, or arterial pressure, whereas aspirin (1 g PO) was without any hemodynamic effect. In the presence of L-NMMA, the peak flow response during hyperemia was not affected (76±12 mL/min), but the duration of the hyperemic response was markedly reduced, and the flow-dependent dilatation of the radial artery was abolished and converted to a vasoconstriction (from 2.62±0.11 to 2.55±0.11 mm; <jats:italic>P</jats:italic> <.01). In contrast, aspirin did not affect the hyperemic response nor the flow-dependent dilatation of the radial artery. </jats:p> <jats:p> <jats:italic>Conclusions</jats:italic> The present investigation demonstrates that NO, but not prostacyclin, is essential for flow-mediated dilatation of large human arteries. Hence, this response can be used as a test for the <jats:sc>l</jats:sc> -arginine/NO pathway in clinical studies. </jats:p>

収録刊行物

  • Circulation

    Circulation 91 (5), 1314-1319, 1995-03

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (39)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ